These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2479112)

  • 1. Characterization of monoclonal antibodies to human tissue-type plasminogen activator: catalytic inhibition and one-two chain discriminatory reactivities.
    Stigbrand T; Frängsmyr L; Bergsdorf N; Wallen P
    Thromb Haemost; 1989 Sep; 62(2):742-7. PubMed ID: 2479112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of human tissue-type plasminogen activator with monoclonal antibodies: mapping of epitopes and binding sites for fibrin and lysine.
    Zacharias U; Fischer B; Noll F; Will H
    Thromb Haemost; 1992 Jan; 67(1):88-94. PubMed ID: 1377416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and characterization of monoclonal antibodies against tissue-type plasminogen activator.
    Ding H; Wang JY; Song HY
    Chin J Biotechnol; 1990; 6(3):223-7. PubMed ID: 2129498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of two monoclonal antibodies against human tissue-type plasminogen activator.
    Schleef RR; Sinha M; Loskutoff DJ
    Thromb Haemost; 1985 Apr; 53(2):170-5. PubMed ID: 4040658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of monoclonal antibodies against human tissue plasminogen activator (tPA): quantitation of free tPA in human cell cultures by an ELISA.
    Kurokawa T; Toyoda Y; Iwasa S
    J Biochem; 1991 Feb; 109(2):217-22. PubMed ID: 1713912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of epitopes on human tissue-type plasminogen activator with recombinant deletion mutant proteins.
    van Zonneveld AJ; Veerman H; Brakenhoff JP; Aarden LA; Cajot JF; Pannekoek H
    Thromb Haemost; 1987 Feb; 57(1):82-6. PubMed ID: 2438798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Functional characterization of a monoclonal antibody which interferes with the binding of t-PA to fibrin].
    Orbe J; Montes R; Chordá C; Páramo JA; Rocha E
    Sangre (Barc); 1994 Aug; 39(4):261-6. PubMed ID: 7985055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assay of human tissue-type plasminogen activator (t-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies to t-PA.
    Holvoet P; Cleemput H; Collen D
    Thromb Haemost; 1985 Oct; 54(3):684-7. PubMed ID: 3937265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of epitopes on human tissue plasminogen activator recognised by a group of monoclonal antibodies.
    MacGregor IR; Micklem LR; James K; Pepper DS
    Thromb Haemost; 1985 Feb; 53(1):45-50. PubMed ID: 2581330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fibrin specific monoclonal antibody which interferes with the fibrinolytic effect of tissue plasminogen activator.
    Gargan PE; Ploplis VA; Scheu JD
    Thromb Haemost; 1988 Jun; 59(3):426-31. PubMed ID: 3142080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells--inhibitor neutralization and one-step affinity purification.
    Nielsen LS; Andreasen PA; Grøndahl-Hansen J; Huang JY; Kristensen P; Danø K
    Thromb Haemost; 1986 Apr; 55(2):206-12. PubMed ID: 3520936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of fibrinolysis by bispecific monoclonal antibodies reactive to fibrin and plasminogen activators.
    Kurokawa T; Iwasa S; Kakinuma A
    Thromb Res Suppl; 1990; 10():83-9. PubMed ID: 2107601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sensitive solid-phase immunosorbent assay for tissue-type plasminogen activator activity in plasma using trinitrobenzoylated poly-D-lysine as a stimulator for plasminogen activation.
    Petersen LC; Handest P; Brender J; Selmer J; Jørgensen M; Thorsen S
    Thromb Haemost; 1987 Apr; 57(2):205-11. PubMed ID: 3110997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.
    Wojta J; Turcu L; Wagner OF; Korninger C; Binder BR
    J Lab Clin Med; 1987 Jun; 109(6):665-71. PubMed ID: 3108431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to plasminogen and tissue plasminogen activator in women with recurrent pregnancy loss.
    Bu C; Zhang C; Li Z; Gao L; Xie Z; Cai G
    Clin Exp Immunol; 2007 Jul; 149(1):31-9. PubMed ID: 17425656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies against the human mannose receptor that inhibit the binding of tissue-type plasminogen activator.
    Barrett-Bergshoeff M; Noorman F; Bos R; Rijken DC
    Thromb Haemost; 1997 Apr; 77(4):718-24. PubMed ID: 9134649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of monoclonal antibodies in the diagnosis of fibrinolysis].
    Wojta J; Korninger C; Kirchheimer J; Hattey E; Turcu L; Binder BR
    Wien Klin Wochenschr; 1985 Mar; 97(5):244-8. PubMed ID: 4039506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice.
    Declerck PJ; Verstreken M; Collen D
    Thromb Haemost; 1995 Nov; 74(5):1305-9. PubMed ID: 8607114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, characterization and application of monoclonal antibodies against PAI-1.
    Ding H; Wu X; Zhou X; Zhu Y; Song H
    Chin J Biotechnol; 1994; 10(2):121-8. PubMed ID: 7803688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of monoclonal antibodies that bind and inhibit tissue-type plasminogen activator.
    Ball EL; Dunlop K; Matsueda GR
    Hybridoma; 1993 Jun; 12(3):317-26. PubMed ID: 8359825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.